{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T02:12:42Z","timestamp":1780452762439,"version":"3.54.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T00:00:00Z","timestamp":1748304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T00:00:00Z","timestamp":1748304000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genomics"],"DOI":"10.1186\/s12920-025-02145-0","type":"journal-article","created":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T12:27:49Z","timestamp":1748348869000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Comprehensive analysis of a novel LYST mutation in a Tunisian patient with Chediak-Higashi syndrome"],"prefix":"10.1186","volume":"18","author":[{"given":"Yessine","family":"Amri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saoussen","family":"Chouchene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajer","family":"Foddha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amani","family":"Abderahmene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikbel","family":"Kooli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adnen","family":"Toumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kawthar","family":"Hadj Khalifa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rihem","family":"Mezrigui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taieb","family":"Messaoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohsen","family":"Hassine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rym","family":"Dabboubi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,27]]},"reference":[{"issue":"12","key":"2145_CR1","first-page":"900","volume":"15","author":"CA B\u00e9guez","year":"1943","unstructured":"B\u00e9guez CA. Neutropenia cr\u00f3nica Maligna familiar Con granulaciones At\u00edpicas de Los leucocitos. Bol Soc Cuba Pediatr. 1943;15(12):900\u201322.","journal-title":"Bol Soc Cuba Pediatr"},{"key":"2145_CR2","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s13023-014-0132-6","volume":"9","author":"ML Lozano","year":"2014","unstructured":"Lozano ML, Rivera J, S\u00e1nchez-Guiu I, et al. Towards the targeted management of Ch\u00e9diak-Higashi syndrome. Orphanet J Rare Dis. 2014;9:132. https:\/\/doi.org\/10.1186\/s13023-014-0132-6.","journal-title":"Orphanet J Rare Dis"},{"key":"2145_CR3","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1136\/jmg-2023-109420","volume":"61","author":"M Morimoto","year":"2024","unstructured":"Morimoto M, Nicoli E, Kuptanon C, et al. Spectrum of LYST mutations in Chediak-Higashi syndrome: a report of novel variants and a comprehensive review of the literature. J Med Genet. 2024;61:212\u201323.","journal-title":"J Med Genet"},{"issue":"6588","key":"2145_CR4","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/382262a0","volume":"382","author":"MD Barbosa","year":"1996","unstructured":"Barbosa MD, Nguyen QA, Tchernev VT, et al. Identification of the homologous beige and Chediak-Higashi syndrome genes. Nature. 1996;382(6588):262\u20135. https:\/\/doi.org\/10.1038\/382262a0.","journal-title":"Nature"},{"key":"2145_CR5","doi-asserted-by":"publisher","first-page":"1072784","DOI":"10.3389\/fgene.2023.1072784","volume":"14","author":"C Kuptanon","year":"2023","unstructured":"Kuptanon C, Morimoto M, Nicoli ER, et al. cDNA sequencing increases the molecular diagnostic yield in Chediak-Higashi syndrome. Front Genet. 2023;14:1072784. https:\/\/doi.org\/10.3389\/fgene.2023.1072784.","journal-title":"Front Genet"},{"key":"2145_CR6","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.hemonc.2015.07.002","volume":"9","author":"I Maaloul","year":"2016","unstructured":"Maaloul I, Talmoudi J, Chabchoub I, et al. Chediak-Higashi syndrome presenting in accelerated phase: A case report and literature review. Hematol Oncol Stem Cell Ther. 2016;9:71\u20135.","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"2145_CR7","first-page":"161","volume":"20","author":"S Chouch\u00e8ne","year":"2014","unstructured":"Chouch\u00e8ne S, Abderrazak F, Hammami S, et al. Chediak-Higashi syndrome: a case report and literature review. Hematologie. 2014;20:161\u20135.","journal-title":"Hematologie"},{"key":"2145_CR8","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s12288-014-0336-x","volume":"30","author":"A Bouatay","year":"2014","unstructured":"Bouatay A, Hizem S, Tej A, et al. Chediak-Higashi syndrome presenting in accelerated phase: a case report and literature review. Indian J Hematol Blood Transfus. 2014;30:223\u20136.","journal-title":"Indian J Hematol Blood Transfus"},{"key":"2145_CR9","doi-asserted-by":"publisher","first-page":"1404846","DOI":"10.3389\/fimmu.2024.1404846","volume":"15","author":"ME Turner","year":"2024","unstructured":"Turner ME, Che J, Mirhaidari GJM, et al. The lysosomal trafficking regulator LYST: an 80-year traffic jam. Front Immunol. 2024;15:1404846. https:\/\/doi.org\/10.3389\/fimmu.2024.1404846.","journal-title":"Front Immunol"},{"key":"2145_CR10","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-87893-1_33","volume-title":"Neurocutaneous disorders","author":"R Benjamin","year":"2022","unstructured":"Benjamin R. Ch\u00e9diak-Higashi syndrome. In: Panteliadis CP, Benjamin R, Hagel C, editors. Neurocutaneous disorders. Cham: Springer; 2022. https:\/\/doi.org\/10.1007\/978-3-030-87893-1_33."},{"key":"2145_CR11","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/1750-1172-8-168","volume":"8","author":"L Dotta","year":"2013","unstructured":"Dotta L, Parolini S, Prandini A, et al. Clinical, laboratory and molecular signs of immunodeficiency in patients with partial oculo-cutaneous albinism. Orphanet J Rare Dis. 2013;8:168. https:\/\/doi.org\/10.1186\/1750-1172-8-168.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"2145_CR12","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1182\/asheducation-2013.1.605","volume":"2013","author":"EJ Gritta","year":"2013","unstructured":"Gritta EJ, Lehmberg K. Hemophagocytic lymphohistiocytosis: pathogenesis and treatment. Hematol Am Soc Hematol Educ Program. 2013;2013(1):605\u201311. https:\/\/doi.org\/10.1182\/asheducation-2013.1.605.","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"2145_CR13","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/nprot.2015.053","volume":"10","author":"L Kelley","year":"2015","unstructured":"Kelley L, Mezulis S, Yates C, et al. The Phyre2 web portal for protein modeling, prediction and analysis. Nat Protoc. 2015;10:845\u201358. https:\/\/doi.org\/10.1038\/nprot.2015.053.","journal-title":"Nat Protoc"},{"key":"2145_CR14","doi-asserted-by":"crossref","unstructured":"Waterhouse A, Bertoni M, Bienert S et al. SWISS-MODEL: homology modelling of protein structures and complexes. Nucleic Acids Res. 2018;46.","DOI":"10.1093\/nar\/gky427"},{"issue":"1","key":"2145_CR15","first-page":"71","volume":"15","author":"K Baruah","year":"2023","unstructured":"Baruah K, Sharma D, Dey B, et al. Chediak-Higashi syndrome: A rare case report with review of literature. J Lab Physicians. 2023;15(1):71\u20134.","journal-title":"J Lab Physicians"},{"issue":"4","key":"2145_CR16","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1097\/MOH.0000000000000766","volume":"30","author":"ML Talbert","year":"2023","unstructured":"Talbert ML, Malicdan MCV, Introne WJ. Chediak-Higashi syndrome. Curr Opin Hematol. 2023;30(4):144\u201351. https:\/\/doi.org\/10.1097\/MOH.0000000000000766.","journal-title":"Curr Opin Hematol"},{"key":"2145_CR17","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/BF03402003","volume":"8","author":"VT Tchernev","year":"2002","unstructured":"Tchernev VT, Mansfield TA, Giot L, et al. The Chediak-Higashi protein interacts with SNARE complex and signal transduction proteins. Mol Med. 2002;8:56\u201364. https:\/\/doi.org\/10.1007\/BF03402003.","journal-title":"Mol Med"},{"key":"2145_CR18","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.ddmod.2019.10.008","volume":"31","author":"P Sharma","year":"2020","unstructured":"Sharma P, Nicoli ER, Serra-Vinardell J, et al. Chediak-Higashi syndrome: a review of the past, present, and future. Drug Discov Today Dis Models. 2020;31:31\u20136. https:\/\/doi.org\/10.1016\/j.ddmod.2019.10.008.","journal-title":"Drug Discov Today Dis Models"},{"issue":"4","key":"2145_CR19","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1111\/j.1346-8138.1993.tb03867.x","volume":"20","author":"K Fukai","year":"1993","unstructured":"Fukai K, Ishii M, Kadoya A, Chanoki M, Hamada T. Ch\u00e9diak-Higashi syndrome: report of a case and review of the Japanese literature. J Dermatol. 1993;20(4):231\u20137. https:\/\/doi.org\/10.1111\/j.1346-8138.1993.tb03867.x.","journal-title":"J Dermatol"},{"issue":"1","key":"2145_CR20","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1002\/ajmg.10184","volume":"108","author":"MA Karim","year":"2002","unstructured":"Karim MA, Suzuki K, Fukai K, et al. Apparent genotype-phenotype correlation in childhood, adolescent, and adult Chediak-Higashi syndrome. Am J Med Genet. 2002;108(1):16\u201322.","journal-title":"Am J Med Genet"},{"key":"2145_CR21","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s00401-006-0092-6","volume":"112","author":"M Rudelius","year":"2006","unstructured":"Rudelius M, Osanger A, Kohlmann S, et al. A missense mutation in the WD40 domain of murine Lyst is linked to severe progressive purkinje cell degeneration. Acta Neuropathol. 2006;112:267\u201376. https:\/\/doi.org\/10.1007\/s00401-006-0092-6.","journal-title":"Acta Neuropathol"},{"issue":"10","key":"2145_CR22","doi-asserted-by":"publisher","first-page":"800","DOI":"10.3390\/cells13100800","volume":"13","author":"M Laurent","year":"2024","unstructured":"Laurent M, Geoffroy M, Pavani G, Guiraud S. CRISPR-based gene therapies: from preclinical to clinical treatments. Cells. 2024;13(10):800. https:\/\/doi.org\/10.3390\/cells13100800.","journal-title":"Cells"},{"issue":"3","key":"2145_CR23","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.jcyt.2022.11.014","volume":"25","author":"L Ugalde","year":"2023","unstructured":"Ugalde L, Fa\u00f1anas S, Torres R, et al. CRISPR\/Cas9-mediated gene editing: A promising strategy in hematological disorders. Cytotherapy. 2023;25(3):277\u201385. https:\/\/doi.org\/10.1016\/j.jcyt.2022.11.014.","journal-title":"Cytotherapy"},{"issue":"8","key":"2145_CR24","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.3390\/biom10081110","volume":"10","author":"EV Pinto","year":"2020","unstructured":"Pinto EV, Vairo F, Rojas M\u00e1laga D, et al. Precision medicine for lysosomal disorders. Biomolecules. 2020;10(8):1110. https:\/\/doi.org\/10.3390\/biom10081110.","journal-title":"Biomolecules"},{"key":"2145_CR25","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.3389\/fimmu.2019.01672","volume":"10","author":"A Lev","year":"2019","unstructured":"Lev A, Simon AJ, Barel O, et al. Reduced function and diversity of T cell repertoire and distinct clinical course in patients with IL7RA mutation. Front Immunol. 2019;10:1672. https:\/\/doi.org\/10.3389\/fimmu.2019.01672.","journal-title":"Front Immunol"}],"container-title":["BMC Medical Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-025-02145-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12920-025-02145-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-025-02145-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T12:27:51Z","timestamp":1748348871000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedgenomics.biomedcentral.com\/articles\/10.1186\/s12920-025-02145-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,27]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2145"],"URL":"https:\/\/doi.org\/10.1186\/s12920-025-02145-0","relation":{},"ISSN":["1755-8794"],"issn-type":[{"value":"1755-8794","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,27]]},"assertion":[{"value":"24 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was carried out under the principles of theDeclaration of Helsinki developed by the World Medical Association and approved by the Human Ethics committee of Fattouma Bourguiba University Hospital of Monastir (Approval Number: HUFB \u2212\u20092024 \/ 87). Informed consent to participate was obtained from all participants after receiving all the necessary information about the research. All data and identities of patients were processed with strict confidentiality.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication of personal and clinical details was obtained from all participants and the parents of the minor patient. This consent was obtained in accordance with ethical guidelines and institutional regulations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"95"}}